(Finance) – DiaSorinan Italian multinational active in the field of diagnostics included in the FTSE MIB, has announced that the Court of Pavia declared there was no place to proceed because “the fact does not exist” in relation to the criminal proceedings opened by the Public Prosecutor’s Office of Pavia against the CEO Carlo Rosa and the CTO Fabrizio Bonelli for the crime of embezzlement.
According to the Public Prosecutor’s statement, Diasorin – within the scope of the collaboration agreement signed with the IRCCS San Matteo Foundation of Pavia on March 20, 2020 – would have received from the latter “economic benefits consisting of a “Pool” of sera with a high antibody content … for a quantity close to 400ml, which would have guaranteed the production … of the LIAISON XL COVID-19 IgG serological test for a duration of 5 years”.
The GUP of the Court of Pavia “has the accusatory castle was completely dismantled constructed by the Prosecutor’s Office, noting its total groundlessness”, we read in a note from the company.
Diasorin “has never failed to renew its full trust in the actions of the CEO and the Scientific Director, trusting that the absolute inconsistency of even this umpteenth review of the accusatory hypothesis would have been demonstrated” and therefore “today’s decision only confirm the correctness of the company and its managers“.